Market Tracker

07/29 6:45pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.3711
Delayed Data
As of Jul 29
 -0.009 / -2.37%
Today’s Change
0.29
Today|||52-Week Range
1.33
-68.28%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.38
Today’s open0.39
Day’s range0.36 - 0.39
Volume625,553
Average volume (3 months)1,393,223
Market cap$89.3M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book1.75

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV-0.08-2.96%
SMMTSummit Therapeutics ...-0.00-0.07%
SBBPStrongbridge Biophar...-0.00-0.00%
--Innovative Pharmaceu...0.000.00%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateSeptember 5, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts